BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8796321)

  • 1. Crystal structure analysis of subtilisin BPN' mutants engineered for studying thermal stability.
    Gilliland GL; Gallagher DT; Alexander P; Bryan P
    Adv Exp Med Biol; 1996; 379():159-69. PubMed ID: 8796321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of calcium-independent subtilisin BPN' with restored thermal stability folded without the prodomain.
    Almog O; Gallagher T; Tordova M; Hoskins J; Bryan P; Gilliland GL
    Proteins; 1998 Apr; 31(1):21-32. PubMed ID: 9552156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis of thermostability. Analysis of stabilizing mutations in subtilisin BPN'.
    Almog O; Gallagher DT; Ladner JE; Strausberg S; Alexander P; Bryan P; Gilliland GL
    J Biol Chem; 2002 Jul; 277(30):27553-8. PubMed ID: 12011071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystallographic investigations of subtilisin BPN' mutants engineered for studying thermal stability.
    Oliver JD; Rydel TJ; Strickland LC
    Adv Exp Med Biol; 1996; 379():191-201. PubMed ID: 8796324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large increases in general stability for subtilisin BPN' through incremental changes in the free energy of unfolding.
    Pantoliano MW; Whitlow M; Wood JF; Dodd SW; Hardman KD; Rollence ML; Bryan PN
    Biochemistry; 1989 Sep; 28(18):7205-13. PubMed ID: 2684274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporation of a stabilizing Ca(2+)-binding loop into subtilisin BPN'.
    Braxton S; Wells JA
    Biochemistry; 1992 Sep; 31(34):7796-801. PubMed ID: 1510966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of engineered salt bridges on the stability of subtilisin BPN'.
    Erwin CR; Barnett BL; Oliver JD; Sullivan JF
    Protein Eng; 1990 Oct; 4(1):87-97. PubMed ID: 2127106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Furilisin: a variant of subtilisin BPN' engineered for cleaving tribasic substrates.
    Ballinger MD; Tom J; Wells JA
    Biochemistry; 1996 Oct; 35(42):13579-85. PubMed ID: 8885837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free energy perturbation techniques applied to subtilisin BPN' stability.
    Barnett BL; Turner CB
    Adv Exp Med Biol; 1996; 379():121-31. PubMed ID: 8796316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme engineering for nonaqueous solvents. II. Additive effects of mutations on the stability and activity of subtilisin E in polar organic media.
    Chen KQ; Robinson AC; Van Dam ME; Martinez P; Economou C; Arnold FH
    Biotechnol Prog; 1991; 7(2):125-9. PubMed ID: 1367168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing subtilisin BPN' to cleave substrates containing dibasic residues.
    Ballinger MD; Tom J; Wells JA
    Biochemistry; 1995 Oct; 34(41):13312-9. PubMed ID: 7577915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The refined crystal structure of subtilisin Carlsberg at 2.5 A resolution.
    Neidhart DJ; Petsko GA
    Protein Eng; 1988 Oct; 2(4):271-6. PubMed ID: 3150541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The crystal structure of an autoprocessed Ser221Cys-subtilisin E-propeptide complex at 2.0 A resolution.
    Jain SC; Shinde U; Li Y; Inouye M; Berman HM
    J Mol Biol; 1998 Nov; 284(1):137-44. PubMed ID: 9811547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein engineering of disulfide bonds in subtilisin BPN'.
    Mitchinson C; Wells JA
    Biochemistry; 1989 May; 28(11):4807-15. PubMed ID: 2504281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering the independent folding of the subtilisin BPN' prodomain: analysis of two-state folding versus protein stability.
    Ruvinov S; Wang L; Ruan B; Almog O; Gilliland GL; Eisenstein E; Bryan PN
    Biochemistry; 1997 Aug; 36(34):10414-21. PubMed ID: 9265621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of the alkaline proteinase Savinase from Bacillus lentus at 1.4 A resolution.
    Betzel C; Klupsch S; Papendorf G; Hastrup S; Branner S; Wilson KS
    J Mol Biol; 1992 Jan; 223(2):427-45. PubMed ID: 1738156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering thermostability in subtilisin BPN' by in vitro mutagenesis.
    Rollence ML; Filpula D; Pantoliano MW; Bryan PN
    Crit Rev Biotechnol; 1988; 8(3):217-24. PubMed ID: 3145814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and function of subtilisin BPN' as studied through crystallographic studies on a series of its complexes with genetically engineered proteinaceous inhibitor SSI.
    Nonaka T; Suzuki T; Tanaka N; Saito S; Senda T; Miura K; Mitsui Y
    Adv Exp Med Biol; 1996; 379():21-7. PubMed ID: 8796307
    [No Abstract]   [Full Text] [Related]  

  • 19. Contribution of long-range electrostatic interactions to the stabilization of the catalytic transition state of the serine protease subtilisin BPN'.
    Jackson SE; Fersht AR
    Biochemistry; 1993 Dec; 32(50):13909-16. PubMed ID: 8268166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of amino acid residues responsible for the changes of absorption and fluorescence spectra on the binding of subtilisin BPN' and Streptomyces subtilisin inhibitor.
    Masuda-Momma K; Shimakawa T; Inouye K; Hiromi K; Kojima S; Kumagai I; Miura K; Tonomura B
    J Biochem; 1993 Dec; 114(6):906-11. PubMed ID: 8138550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.